Herpes simplex virus-infected cells disarm killer lymphocytes.
AUTOR(ES)
Confer, D L
RESUMO
Human endothelial cells or human foreskin fibroblasts infected with herpes simplex viruses (HSVs) potently inhibit the lytic activity of natural killer cells and interleukin 2-activated killer cells. The inhibition occurs after as little as 8 hr of viral infection and requires contact between effector cells and HSV-infected targets. Inhibition evidently stems from direct blockade of killer cell function because killer cells placed atop HSV-infected targets rapidly become incapable of lysing subsequently added HL-60 or K-562 cells. The impairment of killer cell function is prevented when protein glycosylation in HSV-infected cells is blocked with tunicamycin. These studies may be relevant for understanding the persistence of herpes simplex virus infections and, further, suggest a mechanism for failed immune surveillance.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=53951Documentos Relacionados
- Polysome-associated proteins in herpes simplex virus-infected cells.
- Mapping of a herpes simplex virus type 2-encoded function that affects the susceptibility of herpes simplex virus-infected target cells to lysis by herpes simplex virus-specific cytotoxic T lymphocytes.
- Ontogeny of murine cellular cytotoxicity to herpes simplex virus-infected cells.
- Murine cellular cytotoxicity to syngeneic and xenogeneic herpes simplex virus-infected cells.
- Psoralen inactivation of influenza and herpes simplex viruses and of virus-infected cells.
